MedNova Health is a mid-sized healthcare technology company that sells care management and clinical workflow software to US provider organizations. The company generates $180M in annual revenue, serves 220 hospital systems and large physician groups, and has historically grown at 11% per year. Its core products are mature, but growth has slowed as buyers increasingly ask about AI-enabled documentation, remote monitoring, ambient scribing, and interoperability automation. The CEO wants a more systematic way to stay current with emerging technologies in healthcare so MedNova can make better product, partnership, and acquisition decisions.
You are the newly hired Director of Strategy. Today, MedNova tracks healthcare innovation informally through conferences, vendor demos, and customer conversations. As a result, the company often reacts late: it missed the first wave of ambient AI pilots and only recently began evaluating remote patient monitoring partnerships. The executive team is considering whether to build a formal technology intelligence function that continuously monitors emerging technologies, evaluates commercial relevance, and translates insights into product and go-to-market actions.
The question is not simply how to read industry news. The decision is whether MedNova should invest in a structured capability, what that capability should cover, and how it should influence strategic choices over the next 12 months.
| Metric | Value | Notes |
|---|---|---|
| Annual revenue | $180M | 78% recurring software revenue |
| Revenue growth | 11% YoY | Down from 17% two years ago |
| R&D budget | $24M | Roughly 13% of revenue |
| Available incremental strategy budget | $3M | For new initiatives this fiscal year |
| Enterprise customer renewal rate | 92% | But expansion revenue slowed to 4% YoY |
Additional market signals: